Trial Profile
Reducing Cardiovascular Risk in Type 2 Diabetes: The effect of nicotinic acid prolonged release on postprandial lipoproetin metabolism in men with type 2 diabetes.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Jun 2016
Price :
$35
*
At a glance
- Drugs Niacin (Primary)
- Indications Hyperlipidaemia
- Focus Pharmacodynamics
- Acronyms DIME
- 28 Jul 2011 Status changed from not yet recruiting to completed as reported by Australian New Zealand Clinical Trials Registry.
- 15 Jun 2009 New trial record